A new model for raf kinase inhibitory protein induced chemotherapeutic resistance.
Therapeutic resistance remains the most challenging aspect of treating cancer. Raf kinase inhibitory protein (RKIP) emerged as a molecule capable of sensitizing cancerous cells to radio- and chemotherapy. Moreover, this small evolutionary conserved molecule, endows significant resistance to cancer t...
Main Authors: | Fahd Al-Mulla, Milad S Bitar, Jingwei Feng, Sungdae Park, Kam C Yeung |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3261143?pdf=render |
Similar Items
-
Targeting Raf Kinase Inhibitory Protein Regulation and Function
by: Ali Ekrem Yesilkanal, et al.
Published: (2018-09-01) -
Expression and Significance of Raf Kinase Inhibitory Protein
in Lung Cancer
by: Dayun YANG, et al.
Published: (2012-10-01) -
Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.
by: Saad Yousuf, et al.
Published: (2014-01-01) -
MAP kinase meets mitosis: A role for Raf Kinase Inhibitory Protein in spindle checkpoint regulation
by: Rosner Marsha
Published: (2007-01-01) -
Transcriptional Repression of Raf Kinase Inhibitory Protein Gene by Metadherin during Cancer Progression
by: Trang Huyen Lai, et al.
Published: (2021-03-01)